According to Verona Pharma's latest financial reports and stock price the company's current Operating Margin is -138.96%. At the end of 2021 the company had an Operating Margin of -138.97%.
Year | Operating Margin | Change |
---|---|---|
2021 | -138.97% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -234,760.00% | 168,840.70% | Bahamas |
NRC Health
NRC | 32.86% | -123.65% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.